Provider review
FitRx review
Publishes a four-figure cash price beside a copay headline for the same drugs.
Both routes on one page, which most sellers do not manage. The small number depends on a plan this provider neither sets nor sees.
Reviewed by Lena OrtizMetabolic Health Editor
Price updated August 2026
How we’re funded. Some links here are affiliate links: start care through one and we may earn a commission, at no extra cost to you. Affiliate partners are listed first on our rankings — what we write about a provider is the same either way, and unflattering findings about one that pays us stay in. Full disclosure.
Price as published
FitRx
Branded as low as $25/mo with insurance; four figures without it
FDA warning letter · FitRx · February 2026 · addressed to FitRX, LLC dba FitRx. Details in our review.
- Vs median
- Not comparable — the figure is an insurance copay outcome rather than a price the provider sets, so it depends on a plan we cannot read
- Market
- $59–$1300/mo across 242 of 373
- Structure
- Standard plan, self-directed low dose
- Dispensed
- Pharmacy not publicly identified
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
In one paragraph
The verdict
Both routes are priced on a single page, which most sellers reviewed here do not manage: an insurance copay figure for the branded GLP-1s, and a four-figure cash price for the identical medicines set beside it. That gap is the most important fact about branded pricing, and having it laid out rather than discovered after enrollment is genuinely useful. The caution attaches to the small number. It is a copay outcome depending on a plan this provider neither sets nor sees, so nobody can budget from it without checking their own coverage first, and putting it in the headline invites exactly that mistake. No dose is published behind any figure and no compounding pharmacy is named. On the evidence, the site attaches a clinical-trial weight-loss range to compounded products when those trials tested the branded medicines. As context rather than criticism: this brand runs on a shared telehealth platform used by two others reviewed here, with the same prices and much of the same copy. That is unremarkable in this industry and says nothing about the care — it matters only so that agreement between the three is not mistaken for independent confirmation.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
Who it suits, and who it does not
A good fit if
- You want the insured and uninsured paths priced on the same page.
- You want access to the branded GLP-1s rather than compounded alone.
- You want the FAQ to address billing terms directly.
Look elsewhere if
- You want the compounding pharmacy named. It is not.
- You are planning around the headline. It is a copay outcome, not a price.
- You want a dose behind the figure. None is published.
What it actually costs
Price as published
Identical pricing, FAQ and 27 verbatim sentences to Zealthy and Roen Rx — the same "as low as $25/month" with insurance, the same roughly $1,349 cash figure for the branded drugs, the same FAQ laid out identically — while carrying its own copyright and presenting as an independent company · the three were found by noticing that their extracted price sets and GLP-1 term counts matched exactly, which is not something three unrelated sites do · as with its siblings, the headline is an insurance copay outcome rather than a price, and the shared copy attaches a "15-20% average weight loss" trial figure to compounded products
- Vs median
- Not comparable — the figure is an insurance copay outcome rather than a price the provider sets, so it depends on a plan we cannot read
- Market
- $59–$1300/mo is the full published spread in our ranking
- Structure
- Standard plan, self-directed low dose
No low-dose product of its own. Starting low means asking for a smaller amount inside a standard plan, at the standard plan's price.
152 of the 373 programs we track price a small dose this way. The third storefront on the same platform as Zealthy and Roen Rx. Headline is an insurance copay outcome rather than a price the provider sets. No low-dose product is offered.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
What is included
- Consult
- Included in the price
- Dietitian
- Not included
- Labs
- Not required
- Pricing
- Varies by dose, plan or tier
- Price last updated
- August 2026
What it does well
- Prices the insured and uninsured paths on the same page rather than one of them.
- Carries the branded GLP-1s rather than compounded preparations alone.
- The FAQ addresses billing and membership terms directly.
Pharmacy, labs and oversight
FitRx dispenses through a Not named facility. No bloodwork is required before you start. A clinician review is included in the price.
Transparency check
1 of 4 published openly
What FitRx publishes about itself, read from its own pages when we verified them — not estimated, and not a score.
- Pharmacy named and regulatedNo pharmacy is identified anywhere we could find on its own pages.
- Published
- A price you can read before intakeThe figure appears only after an intake quiz, so it cannot be compared before signing up.
- Not published
- What a higher dose costsPriced by dose, plan or tier, and the higher rungs are not published — the advertised figure does not tell you what a larger dose costs.
- Not published
- FDA warning letter on fileOne is on file. The disclosure and the FDA's own database are directly below.
- On file
FDA warning letter
The U.S. Food and Drug Administration issued a warning letter to FitRx in February 2026. It is addressed to FitRX, LLC dba FitRx — search that name, not ours, to find it. We are not summarizing what it says — read it at the source. This does not change how FitRx is listed here or whether we are paid for a click to it, and we would rather you knew both of those things at once.
How the program works
Both routes are priced on one page, which is more than most manage: an insurance copay figure for the branded GLP-1s and a four-figure cash price for the same medicines directly beside it. That gap is the most important fact about branded pricing and it is laid out rather than left to be discovered after signing up. The caution is the small number. It is a copay outcome that depends on a plan this provider neither sets nor sees, so it is not a rate anyone can budget from without checking their own coverage first. No dose is published behind any figure, and no compounding pharmacy is named. On the evidence, the site attaches a clinical-trial weight-loss range to compounded products, and those trials tested the branded medicines instead. Context rather than criticism: this brand runs on a shared telehealth platform used by two others reviewed here, with the same prices and much of the same copy. That is ordinary in this industry and implies nothing about the care — it is worth knowing only so that agreement between the three is not mistaken for independent confirmation.
The honest cons
No dose is published behind any figure, and no compounding pharmacy is named.
- The headline figure is an insurance copay outcome rather than a price.
- The shared copy attaches a clinical-trial figure to compounded products.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
How it compares
FitRx is one of 373 low-dose GLP-1 programs we track, and 242 of them publish a monthly rate you can read before signing up. The ranking lists every published price on one screen, ordered with the companies that pay us first — a mechanism we state there, on the page it applies to.
Where this sits
#221 of 373
Ordered with the companies that pay us first, and FitRx is not one of them. A disclosed partition, not a score.
Compare all 373 providers →Read this before you buy
Intentional GLP-1 microdosing is off-label and unproven — no randomized trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
The closest alternative
RxSpan MD
From $194/mo
- Vs median
- $25/mo above the $169 median
- Market
- $59–$1300/mo across 242 of 373
- Structure
- Standard plan, self-directed low dose
- Dispensed
- Pharmacy not publicly identified
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
Read the RxSpan MD review →Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.